Dr. Ibrahim El Halabi, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 4760 Woodmere Blvd, Montgomery, AL 36106 Phone: 334-288-0814 Fax: 334-288-3417 |
Rodney Terrell Smith, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4760 Woodmere Blvd, Montgomery, AL 36106 Phone: 334-288-0814 Fax: 334-288-3417 |
Melanie Halvorson, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4760 Woodmere Blvd, Montgomery, AL 36106 Phone: 334-288-0814 Fax: 334-288-3417 |
Robert Boyd Hoit Jr., MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4760 Woodmere Blvd, Montgomery, AL 36106 Phone: 334-288-0814 Fax: 334-288-3417 |
Dhruva Patel, AGACNP--BC Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 239 Mitylene Park Dr, Montgomery, AL 36117 Phone: 334-603-6626 Fax: 334-239-7808 |
Dr. Jogy Varghese, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4163 Lomac St, Montgomery, AL 36106 Phone: 334-396-5570 Fax: 334-396-5572 |
Dr. Avinash C Pradhan, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 215 Perry Hill Rd, Cavhcs, Montgomery, AL 36109 Phone: 334-272-4670 Fax: 334-273-6225 |
Kim Rudolph Mcglothan, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4760 Woodmere Blvd, Montgomery, AL 36106 Phone: 334-288-0814 Fax: 334-288-3417 |
News Archive
STAAR Surgical Company, the leading developer, manufacturer and marketer of minimally invasive refractive lenses, today announced that its Visian Toric Implantable Collamer Lens has been approved by the Japanese Ministry of Health, Labor and Welfare.
Targeting cholesterol metabolism in the eye might help prevent a severe form of age-related macular degeneration (AMD), one of the most common causes of blindness in older Americans, according to indications in a study in mice, which was supported by the National Institutes of Health.
Inspire Medical Systems, a leading developer of neuro-stimulation therapies for the treatment of obstructive sleep apnea (OSA), announced today that the company has received approval from the U.S. Food and Drug Administration (FDA) to begin its STAR pivotal clinical trial. The STAR trial (Stimulation Therapy for Apnea Reduction), is a multi-center study that will evaluate both the safety and effectiveness of Inspire Upper Airway Stimulation (UAS) therapy in patients with moderate to severe obstructive sleep apnea (OSA).
Whitehead Institute researchers have identified the pre-mouth array-an area of the developing face in embryonic frogs-that "unzips" to surround the mouth opening. Their work highlights the precision necessary to create the mouth and identifies the cellular mechanisms that drive its formation.
› Verified 2 days ago